0001437749-24-018133.txt : 20240523 0001437749-24-018133.hdr.sgml : 20240523 20240523154257 ACCESSION NUMBER: 0001437749-24-018133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240521 FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tarnok Michael P. CENTRAL INDEX KEY: 0001413525 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32513 FILM NUMBER: 24977875 BUSINESS ADDRESS: BUSINESS PHONE: (212) 531-5965 MAIL ADDRESS: STREET 1: KERYX BIOPHARMACEUTICALS, INC. STREET 2: 750 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYADIC INTERNATIONAL INC CENTRAL INDEX KEY: 0001213809 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 450486747 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1044 NORTH U.S. HIGHWAY ONE STREET 2: SUITE 201 CITY: JUPITER STATE: FL ZIP: 33477 BUSINESS PHONE: 561-743-8333 MAIL ADDRESS: STREET 1: 1044 NORTH U.S. HIGHWAY ONE STREET 2: SUITE 201 CITY: JUPITER STATE: FL ZIP: 33477 FORMER COMPANY: FORMER CONFORMED NAME: CCP WORLDWIDE INC DATE OF NAME CHANGE: 20030110 4 1 rdgdoc.xml FORM 4 X0508 4 2024-05-21 0001213809 DYADIC INTERNATIONAL INC DYAI 0001413525 Tarnok Michael P. C/O DYADIC INTERNATIONAL, INC. 1044 NORTH U.S. HIGHWAY ONE, SUITE 201 JUPITER FL 33477-5094 1 0 Common Stock 2024-05-21 4 M 0 7500 1.36 A 223603 D Common Stock 2024-05-21 4 M 0 5625 1.36 A 229228 D Common Stock 2024-05-21 4 M 0 16875 1.36 A 246103 D Common Stock 2024-05-21 4 F 0 24431 1.67 D 221672 D Stock Option 1.36 2024-05-21 4 M 0 7500 0 D 2014-06-12 2024-06-11 Common Stock 7500 0 D Stock Option 1.36 2024-05-21 4 M 0 5625 0 D 2015-06-12 2024-06-11 Common Stock 5625 0 D Stock Option 1.36 2024-05-21 4 M 0 16875 0 D 2015-12-31 2024-06-11 Common Stock 16875 0 D The reporting person exercised a total of 30,000 stock options and paid the exercise price through the withholding by the Issuer of 24,431 shares of common stock underlying the stock options (equal to the value of the exercise price), based on a market price of $1.67, which was the closing price of the Issuer's common stock on May 21, 2024. /s/ Ping Rawson, attorney-in-fact 2024-05-23